AbbVie Inc. - Common Stock (ABBV)

CUSIP: 00287Y109

Q2 2022 13F Holders as of 30 Jun 2022

Holder snapshot 7 signals
Share change
+23,082,536
Put/Call ratio
83%
SEC-reported price per share
$153.16
Indexed holders
2,980
Value change
+$3,489,007,770
Number of buys
1,238
Open additional details 1 more signal available
Number of sells
1,446
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
1,769,960,826

Security key

00287Y109

Report period

Q2 2022

Indexed institutions

2,980

Top holders

10

Ownership snapshot

Top reported holders of ABBV - AbbVie Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
31 Mar 2022
13F Highest disclosed value: $24,400,600,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC has the largest disclosed position value at $24.4B.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value Top 5
VANGUARD GROUP INC $24.4B
BlackRock Finance, Inc. $21.01B
STATE STREET CORP $12.65B
JPMORGAN CHASE & CO $8.77B
PRICE T ROWE ASSOCIATES INC /MD/ $5.95B

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$24,400,600,000
150,518,780 shares
— 31 Mar 2022
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$21,014,462,000
129,630,878 shares
— 31 Mar 2022
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$12,650,772,000
78,038,196 shares
— 31 Mar 2022
JPMORGAN CHASE & CO
13F
Company
13F
—
denominator unverified
$8,769,211,000
54,094,198 shares
— 31 Mar 2022
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$5,954,645,000
36,732,127 shares
— 31 Mar 2022
Capital International Investors
13F
Company
13F
—
denominator unverified
$4,943,993,000
30,497,767 shares
— 31 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
2,980
Shares
1,217,745,031
Indexed holders
2,980
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 indexed holders
3,033
Q2 2022 indexed holders
2,980
Indexed holder difference
-53
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 value Q2 2022 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .